Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
| Molecular Weight | 268.23 g/mol |
|---|---|
| Molecular Formula | C10H12N4O5 |
| XLogP3 | -2.1 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 2 |
| Exact Mass | 268.08076950 g/mol |
| Monoisotopic Mass | 268.08076950 g/mol |
| Topological Polar Surface Area | 129 A^2 |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 405 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
Analytical Methods
ABOUT THIS PAGE
A Inosine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Inosine, including repackagers and relabelers. The FDA regulates Inosine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Inosine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Inosine supplier is an individual or a company that provides Inosine active pharmaceutical ingredient (API) or Inosine finished formulations upon request. The Inosine suppliers may include Inosine API manufacturers, exporters, distributors and traders.
click here to find a list of Inosine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Inosine DMF (Drug Master File) is a document detailing the whole manufacturing process of Inosine active pharmaceutical ingredient (API) in detail. Different forms of Inosine DMFs exist exist since differing nations have different regulations, such as Inosine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Inosine DMF submitted to regulatory agencies in the US is known as a USDMF. Inosine USDMF includes data on Inosine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Inosine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Inosine suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Inosine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Inosine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Inosine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Inosine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Inosine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Inosine suppliers with NDC on PharmaCompass.
Inosine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Inosine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Inosine GMP manufacturer or Inosine GMP API supplier for your needs.
A Inosine CoA (Certificate of Analysis) is a formal document that attests to Inosine's compliance with Inosine specifications and serves as a tool for batch-level quality control.
Inosine CoA mostly includes findings from lab analyses of a specific batch. For each Inosine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Inosine may be tested according to a variety of international standards, such as European Pharmacopoeia (Inosine EP), Inosine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Inosine USP).
LOOKING FOR A SUPPLIER?
